Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2

NCT03220399 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decided to stop drug development

Conditions

Healthy

Interventions

DRUG: NVP-1603-1 (P)
DRUG: NVP-1603-2 (T)
DRUG: NVP-1603-1 and NVP-1603-2 (P+T)

Sponsor

NVP Healthcare